AlphaFold predicted structure
GYG1 · P46976

Mean pLDDT
84.3/ 100
Confident
350 residues
Confidence breakdown
- Very high(≥ 90)57%
- Confident(70–90)24%
- Low(50–70)10%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glycogenin 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalHypertrophic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Ketotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomal+1 more panels — install the extension to see the full list inline on any page.
polyglucosan body myopathy type 2
glycogen storage disease XV
Glycogen storage disease due to glycogenin deficiency
disorder of glycogen metabolism
polyglucosan body myopathy
neurodegenerative disease
allergic contact dermatitis
atrial fibrillation
Acute rhabdomyolysis
hypertrophic cardiomyopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Glycogenin-1
Glycogenin participates in the glycogen biosynthetic process along with glycogen synthase and glycogen branching enzyme. It catalyzes the formation of a short alpha (1,4)-glucosyl chain covalently attached via a glucose 1-O-tyrosyl linkage to internal tyrosine residues and these chains act as primers for the elongation reaction catalyzed by glycogen synthase
GYG1 · P46976

Mean pLDDT
84.3/ 100
Confident
350 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0